RNC Capital Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$634K Buy
4,598
+162
+4% +$21.2K 0.03% 122
2025
Q3
$569K Buy
4,436
+310
+8% +$37.8K 0.03% 125
2025
Q2
$499K Buy
4,126
+450
+12% +$50.7K 0.02% 131
2025
Q1
$410K Buy
3,676
+131
+4% +$13.9K 0.02% 124
2024
Q4
$345K Sell
3,545
-137
-4% -$14.6K 0.02% 130
2024
Q3
$392K Hold
3,682
0.02% 120
2024
Q2
$392K Buy
3,682
+16
+0.4% +$1.61K 0.02% 120
2024
Q1
$355K Sell
3,666
-141
-4% -$14.5K 0.02% 123
2023
Q4
$384K Buy
3,807
+560
+17% +$54.1K 0.02% 115
2023
Q3
$331K Sell
3,247
-279
-8% -$28.3K 0.02% 123
2023
Q2
$356K Sell
3,526
-181
-5% -$18.1K 0.02% 139
2023
Q1
$341K Buy
3,707
+128
+4% +$11.2K 0.02% 147
2022
Q4
$325K Sell
3,579
-495
-12% -$41.7K 0.02% 144
2022
Q3
$310K Sell
4,074
-81
-2% -$6.71K 0.02% 138
2022
Q2
$351K Buy
4,155
+89
+2% +$7.81K 0.02% 142
2022
Q1
$357K Buy
4,066
+140
+4% +$12.1K 0.02% 147
2021
Q4
$343K Buy
3,926
+1,235
+46% +$103K 0.02% 148
2021
Q3
$220K Buy
2,691
+375
+16% +$33.7K 0.01% 169
2021
Q2
$211K Buy
+2,316
New +$206K 0.01% 164
2016
Q3
Sell
-5,148
Closed -$381K 147
2016
Q2
$381K Buy
+5,148
New +$356K 0.04% 98

Other funds holding NVS

RNC Capital Management's NVS Position: Q4 2025 in Review

RNC Capital Management increased its Novartis (NVS) stake by 3.7% in Q4 2025, buying an estimated $21.2K and bringing the position to 4,598 shares worth $634K. The position accounts for 0.03% of the portfolio, ranked #122.

RNC Capital Management first reported a position in NVS in Q2 2016 and has held it in 20 quarters since. 1,508 funds tracked by Wall St. Rank hold NVS as of Q4 2025.

  • RNC Capital Management held 4,598 shares of Novartis worth $634K as of Q4 2025.
  • RNC Capital Management bought 162 Novartis shares in Q4 2025, an estimated $21.2K.
  • Novartis made up 0.03% of RNC Capital Management's portfolio in Q4 2025, its #122 holding.
  • RNC Capital Management first reported a position in Novartis in Q2 2016 and has held it in 20 quarters since.
  • 1,508 funds tracked by Wall St. Rank held Novartis as of Q4 2025.

Based on RNC Capital Management's 13F filing for Q4 2025, filed 3 Feb 2026.